Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunity
Maorong Zhu(Air Force Medical University), W ZHANG(Central Hospital of Wuhan), Zhengcong Cao(Air Force Medical University), Haozhe Qin(Central South University), M Y Li(Air Force Medical University), Guangzhao Yang(Xijing Hospital), Huihui Ou(Air Force Medical University), Yalong He(Air Force Medical University), Dan Zheng(Xijing Hospital), Cheng Zou(Xijing Hospital), Yingqi Zhang(Air Force Medical University), Xiao Liu(Air Force Medical University), Duo Yu(Air Force Medical University), Jintao Gu(Xijing Hospital), Lei He(Air Force Medical University), S. Wang(Air Force Medical University), Kuo Zhang(Air Force Medical University)
Cited by 1
Related Papers
Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma
|ACS Nano|2023|181
Engineered Extracellular Vesicle-Delivered CRISPR/Cas9 for Radiotherapy Sensitization of Glioblastoma
|ACS Nano|2023|116
NaSICON-type materials for lithium-ion battery applications: Progress and challenges
|Nano Energy|2024|55
Exosome-transmitted circCABIN1 promotes temozolomide resistance in glioblastoma via sustaining ErbB downstream signaling
|Journal of Nanobiotechnology|2023|38
Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma
|Journal of Experimental & Clinical Cancer Research|2022|28